Journal profile · Medicine-Internal Medicine
Journal of Diabetes and Metabolic Disorders
ISSN 2251-6581 · Springer Nature · 2 issues per year
Journal of Diabetes and Metabolic Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); hybrid open access; APC about USD 3,990; median 91 days to acceptance (118 articles, last 24 months); 277 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Diabetes and Metabolic Disorders is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Education and Adipokines, Inflammation, and Metabolic Diseases, together about 29.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Internal Medicine
Editor-in-chief Bagher LarijaniPublisher website
Editorial board by country: none in mainland China; most named Iran 28, United States 9, United Kingdom 1, Denmark 1, Egypt 1 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine13.5%
- Diabetes Management and EducationMedicine9.7%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.9%
- Diabetes Management and ResearchMedicine5.7%
- Diabetes Treatment and ManagementMedicine5.5%
- Natural Antidiabetic Agents StudiesMedicine5.3%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.3%
- Diabetic Foot Ulcer Assessment and ManagementMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.1Publisher website ·
- Impact factor (publisher) 2017
- 1.82Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.6Publisher website ·
- CiteScore 2026-06
- 3.4LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.69LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 848OpenAlex ·
- 2-year mean citedness
- 2.17OpenAlex ·
- Self-citation rate
- 4.8%LetPub ·
- Share of gold OA articles
- 10.77%LetPub ·
Volume
- Articles per year
- 265LetPub ·
- Articles per year (publisher)
- 2,018Publisher website ·
- Downloads per year (publisher) 2025
- 618,500Publisher website ·
Articles by year OpenAlex count · 2,212 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 258 | 250 | 114 |
| 2025 | 277 | 276 | 636 |
| 2024 | 167 | 163 | 773 |
| 2023 | 194 | 194 | 1,147 |
| 2022 | 235 | 235 | 2,229 |
| 2021 | 240 | 239 | 3,387 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 59 days – 124 days
- Acceptance to online
- median 14 days (118 articles)
- Submission to online
- median 114 days
- Sample
- 118 articles with submission and acceptance dates (563 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 9 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,990 / EUR 2,990 / GBP 2,590 | — | — | |
| Publisher website | No APC | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, Publication ethics, Open access
- AI use Generative AI Images
LLMs do not satisfy authorship criteria. Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Competing interests must be disclosed. Model summary
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability statements
Data citation recommended. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Compliance with ethical standards section required. Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Journal of Diabetes & Metabolic Disorders, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 2 issues per year
- ISSN
- 2251-6581
- Society / sponsor
- Endocrinology and Metabolism Research Institute
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Diabetes and Metabolic Disorders
What CAS zone is Journal of Diabetes and Metabolic Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Diabetes and Metabolic Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Diabetes and Metabolic Disorders?
The journal's website gives an impact factor of 2.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.4, h-index 66.
How long does peer review take at Journal of Diabetes and Metabolic Disorders?
Based on the dates recorded on 118 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 59–124 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Diabetes and Metabolic Disorders?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Diabetes and Metabolic Disorders based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (28), United States (9) and United Kingdom (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Diabetes and Metabolic Disorders?
According to LetPub and DOAJ records, Journal of Diabetes and Metabolic Disorders is indexed in ESCI and Scopus. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Journal of Diabetes and Metabolic Disorders open access, and what is the APC?
Journal of Diabetes and Metabolic Disorders is a hybrid journal. For open-access publication: APC about USD 3,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .